CHROMagar Serratia 5ltr

Serratia species are implicated in nosocomial infections. In several countries, Serratia marcescens is frequently associated with epidemics in intensive care units and in particular in neonatal and pediatric units.

Surveillance of nosocomial infections requires effective recovery of clinical isolates from faeces, wound exudates and respiratory samples to prevent problems of cross infection and potentially fatal infections. In this context, CHROMagar™ has developed CHROMagar™ Serratia, a culture medium perfectly suited to the search for S. marcescens in faeces.

Serratia is intended for use in the qualitative direct detection of colonization with Serratia marcescens to aid in the prevention and control of Serratia marcescens in intensive care unit (ICU), notably neo-natal. The test is performed with rectal swabs, throat swabs, wound swabs and stools from patients to screen for Serratia colonization. It can also be used in hygiene monitoring in the clinical environment with surface sampling. Results can be interpreted after 18-24 h of aerobic incubation at 35-37 °C.